For blood and money : billionaires, biotech, and the quest for a blockbuster drug
(Book)
Author
Published
New York, N.Y. : W.W. Norton & Company, [2023].
Edition
First edition.
Physical Description
xi, 271 pages ; 24 cm
Status
Summary
Loading Description...
Also in this Series
Checking series information...
Copies
Location | Call Number | Note | Status |
---|---|---|---|
CCL - Douglas - Nonfiction | 615.19 VAR | On Shelf | |
Campbell Co. Public Library - Health and Wellness Collection | WELLNESS 615 VARDI 2023 | Housed in Wellness Neighborhood in Adult Nonfiction | On Shelf |
Laramie Co. Library - Cheyenne - Third Floor | 615 VAR | On Shelf | |
Sheridan Co. - Fulmer Branch - Nonfiction | 616.994 VARDI N | On Shelf | |
Teton Co. Library - Nonfiction | 616.99 VARDI N | On Shelf |
Subjects
Library of Congress Subjects
More Details
Published
New York, N.Y. : W.W. Norton & Company, [2023].
Format
Book
Edition
First edition.
Language
English
Notes
Bibliography
Includes bibliographical references and index.
Summary
"For Blood and Money tells the little-known story of how an upstart biotechnology company created a one-in-a-million cancer drug, and how the core team-denied their share of the profits-went and did it again. In this epic saga of money and science, veteran financial journalist Nathan Vardi explains how the invention of two of the biggest cancer drugs in history became (for their backers) two of the greatest Wall Street bets of all time. In the multibillion-dollar business of biotech, where pharmaceutical companies, the government, hedge funds, and venture capitalists have spent billions on funding, experimentation, and treatments, a single molecule can stop cancer in its tracks-and make the people who find that rare molecule astonishingly rich. For Blood and Money follows a small team at a biotech start-up in California, who have found one of these rare molecules. Their compound, known as a BTK inhibitor, seems to work on a vicious type of leukemia. When patients start rising from their hospice beds, the team knows they're onto something big. What follows is a story of genius, pathos, and drama, in which vivid characters navigate a world of corporate intrigue and ambiguous morality. Vardi's narrative immerses readers in the recent explosion of biotech start-ups. He describes the scientists, doctors, and investors who are risking everything to develop new, life-saving treatments, and introduces suffering patients for whom the stakes are life-or-death. A gripping nonfiction read, For Blood and Money illustrates why it's so hard to bring new drugs to market, explains why they are so expensive, and examines how profit-driven venture capitalists are shaping the future of medicine"--,Provided by publisher.
Reviews from GoodReads
Loading GoodReads Reviews.
Citations
APA Citation, 7th Edition (style guide)
Vardi, N. (2023). For blood and money: billionaires, biotech, and the quest for a blockbuster drug (First edition.). W.W. Norton & Company.
Chicago / Turabian - Author Date Citation, 17th Edition (style guide)Vardi, Nathan. 2023. For Blood and Money: Billionaires, Biotech, and the Quest for a Blockbuster Drug. W.W. Norton & Company.
Chicago / Turabian - Humanities (Notes and Bibliography) Citation, 17th Edition (style guide)Vardi, Nathan. For Blood and Money: Billionaires, Biotech, and the Quest for a Blockbuster Drug W.W. Norton & Company, 2023.
MLA Citation, 9th Edition (style guide)Vardi, Nathan. For Blood and Money: Billionaires, Biotech, and the Quest for a Blockbuster Drug First edition., W.W. Norton & Company, 2023.
Note! Citations contain only title, author, edition, publisher, and year published. Citations should be used as a guideline and should be double checked for accuracy. Citation formats are based on standards as of August 2021.